§ Federal grant opportunity · HT942526BMFRPIIRA
DoW Bone Marrow Failure, Investigator-Initiated Research Award
Christopher L Baker Grants Officer is accepting applications for DoW Bone Marrow Failure, Investigator-Initiated Research Award. The deadline is November 4, 2026 and the published award range is Award amount not published.
Key facts
- Funder
- Christopher L Baker Grants Officer
- Application deadline
- November 4, 2026
- Award range
- Award amount not published
- Eligibility
- Eligibility criteria are published in the funding opportunity announcement.
- Geography
- United States
- Focus areas
- Research
- Opportunity number
- HT942526BMFRPIIRA
Program overview
Summary: Supports studies that further develop mature ideas, expand upon key discoveries, and have the potential to make significant advances in bone marrow (BMF) failure research and/or patient care. Investigator-Initiated Research Award (IIRA) applications may involve translational and clinical research including studies in preclinical models, research with human data and/or anatomical substances, and research with human subjects, as well as correlative studies associated with a clinical trial(s); however, this award mechanism does not support clinical trials. IIRA applications may also support Investigational New Drug (IND)-enabling efforts such as lead compound characterization, and assessments of formulation and stability, absorption, distribution, metabolism and excretion, dose/response and toxicology. Distinctive Features: This funding mechanism allows for a partnering Principal Investigator (PI). Only the initiating PI will submit a pre-application, but both PIs will need to submit full applications. The partnering PI application is an abbreviated package specific to their distinct portion of the research project. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn. This award mechanism requires preliminary data relevant to the proposed project. Applications can support clinical research studies; however, this mechanism does not allow clinical trials.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from Christopher L Baker Grants Officer.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before November 4, 2026, allowing time for registration and validation.
Related grant opportunities
- DoW Bone Marrow Failure, Resource Development Award
- Unlocking Dataset Value for AI-Enabled Scientific Discovery
- Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
- ROSES25: A.15 Biosphere
- Fiscal Year 2027 Defense University Research Instrumentation Program (DURIP)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.